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ORIGINAL ARTICLE
First system for fully-automated multi-criterial treatment planning for a
high-magnetic field MR-Linac applied to rectal cancer
Rik Bijmana , Linda Rossia, Tomas Janssenb, Peter de Ruiterb, Casper Carbaatb, Baukelien van Triestb,
Sebastiaan Breedvelda, Jan-Jakob Sonkeb and Ben Heijmena
aDepartment of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; bDepartment of Radiation Oncology,
The Netherlands Cancer Institute, Amsterdam, The Netherlands
ABSTRACT
Background and purpose: In this study we developed a workflow for fully-automated generation of
deliverable IMRT plans for a 1.5 T MR-Linac (MRL) based on contoured CT scans, and we evaluated
automated MRL planning for rectal cancer.
Methods: The Monte Carlo dose calculation engine used in the clinical MRL TPS (Monaco, Elekta AB,
Stockholm, Sweden), suited for high accuracy dose calculations in a 1.5 T magnetic field, was coupled
to our in-house developed Erasmus-iCycle optimizer. Clinically deliverable plans for 23 rectal cancer
patients were automatically generated in a two-step process, i.e., multi-criterial fluence map optimiza-
tion with Erasmus-iCycle followed by a conversion into a deliverable IMRT plan in the clinical TPS.
Automatically generated plans (AUTOplans) were compared to plans that were manually generated
with the clinical TPS (MANplans).
Results: With AUTOplanning large reductions in planning time and workload were obtained; 4–6 h
mainly hands-on planning for MANplans vs 1 h of mainly computer computation time for
AUTOplans. For equal target coverage, the bladder and bowel bag Dmean was reduced in the
AUTOplans by 1.3Gy (6.9%) on average with a maximum reduction of 4.5Gy (23.8%). Dosimetric meas-
urements at the MRL demonstrated clinically acceptable delivery accuracy for the AUTOplans.
Conclusions: A system for fully automated multi-criterial planning for a 1.5 T MR-Linac was developed
and tested for rectal cancer patients. Automated planning resulted in major reductions in planning
workload and time, while plan quality improved. Negative impact of the high magnetic field on the
dose distributions could be avoided.
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Introduction
With the introduction of MR-Linac (MRL) treatment units
[1,2], the demand for high quality treatment plans has fur-
ther increased to guarantee maximum benefit of the
advanced but expensive in-room MR-guidance. Treatment
sites in the pelvic area, including rectal tumors, are known to
be affected by large motions and anatomy variations [3] and
are therefore interesting candidates for MRL treatment [4].
The unique characteristics and design of the Unity MRL
(Elekta AB, Stockholm, Sweden), investigated in this study,
brings up treatment planning challenges compared to con-
ventional linac treatment. Only a 7MV FFF beam is available
to be used for static IMRT (no VMAT). The couch position is
fixed in the bore in AP and LR directions. High density mate-
rials, such as the cryostat pipe and treatment couch, reduce
the available irradiation angles. The 1.5 T magnetic field, has
an impact on the dose deposition, e.g. due to the electron
return effect (ERE) at regions of large density changes (i.e.,
tissue to air) [5] and the shifting of the build-up region
toward the skin [6]. For rectal cancer with a PTV located
close to the skin in the dorsal side of the patient, this can
result in unacceptable high doses in the patient’s back,
which has to be controlled in (automated) treatment plan-
ning [7].
Automated planning is a hot topic in current radiotherapy
research [8–11]. A recently published review by Hussein et al.
[12] has highlighted possibilities for enhanced plan quality
compared to manual planning, accompanied with clear
reductions in hands-on planning time.
At the Erasmus MC, Erasmus-iCycle has been developed
for fully automated multi-criterial planning. For each patient
a single Pareto-optimal plan is generated. Treatment site spe-
cific configurations (‘wish-lists’), containing hard constraints
and prioritized objectives, are used to ensure that Erasmus-
iCycle generated plans are also clinically favorable [8,9,12]. In
the plan generation for a patient, the objective functions are
sequentially minimized in order of assigned priority while
avoiding violations of imposed constraints. Wish-lists are
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created in iterative tuning procedures that ensure automatic
generation of treatment plans maximally complying with the
clinical planning aims, including their tradeoffs [12,13].
Initially, the goal of a wish-list creation is mimicking the
MANplan quality. Subsequently, the process has an intrinsic
drive to beat the MANplan quality [12,13]. Many studies have
demonstrated superiority of Erasmus-iCycle AUTOplans over
MANplans generated with conventional trial-and-error plan-
ning [9,14–19]. For clinical application at Erasmus MC, the
system is used as a pre-optimizer for automated plan gener-
ation in the FDA-approved clinical TPS [9,14–19].
In this study, we developed a workflow for fully auto-
mated multi-criterial planning for IMRT at the Unity MRL.
AUTOplans for rectal cancer patients were compared with
MANplans regarding planning workload and time, plan qual-
ity, treatment time and delivered MU. Moreover they were
checked for dosimetric delivery accuracy.
Material and methods
Patients
Planning CT-scans of 23 rectal cancer patients, previously
treated at the NKI (The Netherlands Cancer Institute,
Amsterdam), were included in this study. The delineated CTV
consisted of the GTV, expanded isotropically with a margin
of 10mm for subclinical disease, plus regional lymph nodes
(mesorectal, iliac, and depending on GTV location and N-
stage, obturator and/or presacral) with a 5mm margin. To
construct the PTV, the CTV was anisotropically expanded
with a margin of 10mm in all directions except for an expan-
sion up to 15mm anterior from the mesorectal region [3].
The average PTV volume was 1126 cc, range [781–1530 cc]. A
single composite organ at risk (OAR) was constructed as
defined in the clinical protocol, consisting of the bowel bag
and the bladder, but excluding the overlap region with the
PTV. A back structure, was constructed as a helper structure
posterior to the PTV (visible in Figure 3), to avoid unaccept-
able high dose in the back of the patient, arising from the
close proximity of the PTV to the skin, and the ERE (relative
electron density of the couch matrass 0.1) and shifted
build-up related to the high magnetic field.
Manplanning
MANplanning was performed with version 5.4 of the clinical
Unity Monaco TPS (Elekta AB, Stockholm, Sweden), using the
structures described in the previous section. MANplans were
made by planners experienced in planning for rectal cancer
patients according to the local planning control, without any
time constraints . The planners did not have prior knowledge
of the AUTOplans.
For all patients a Step-and-Shoot IMRT plan was gener-
ated for a fixed beam arrangement, consisting of nine beams
at gantry angles 0, 30, 60, 90, 160, 200, 270, 300
and 330 all avoiding irradiation through the cryostat pipe
and high attenuation regions of the MRL treatment couch.
Because of the specific MRL couch/bore geometry
(Introduction), the MRL isocenter and the center of mass of
the PTV did not generally coincide; the isocenter was
fixed relative to the couch in LR- and AP directions, i.e.,
independent of the position of the patient’s PTV, while in
cranial-caudal direction it was set in the center of the PTV
beam eye view.
Prescribed dose for all treatment plans was 50Gy deliv-
ered in 25 fractions. For clinical acceptability, the PTV cover-
age (V95%) had to exceed 99% with V107%<1%. Moreover, the
maximum dose in the back-structure should not exceed
40Gy. Additional planning aims were 1) a low OAR Dmean, 2)
a low patient V40Gy, and 3) a PTV Dmean close to the pre-
scribed dose. Clinically used dose calculation and segment
settings were applied (i.e., 3mm dose calculation grid spac-
ing, 1% Monte Carlo dose uncertainty, 2mm beamlet width.
Minimum segment area and width of 16 cm2 and 5mm,
respectively).
Autoplanning
A fully automated two-step workflow was developed for gen-
eration of MRL AUTOplans. In the first step, Erasmus-iCycle
was used for multi-criterial fluence map optimization (FMO).
To this purpose, the dose calculation engine as used in the
MRL TPS [20,21] was also coupled to Erasmus-iCycle for high
accuracy dose calculations in the 1.5 T magnetic field. In the
next step, the MRL TPS was used to convert the FMO plan
into a deliverable IMRT plan [13].
Five of the 23 included patients were used for wish-list
generation, based on the same planning goals and with the
same treatment aim as used for MANplanning (Manplanning
section of Materials and methods). The final wish-list, as pre-
sented in Table 1, was created in collaboration with the
treating clinician (BvT) for automated treatment plan gener-
ation with clinically desired tradeoffs between all plan-
ning aims.
A series of maximum dose constraints for concentric shells
around the PTV was used to steer the dose conformality (i.e.,
controlling unacceptable spread out of dose). A maximum
dose constraint on the 1 cm entrance dose shell (excluding
the back structure posterior to the PTV) was used to control
the skin dose. A separate maximum dose constraint was
assigned to the back structure in order to steer on the
potentially enhanced dose in the back of the patient related
to anatomy and the high magnetic field (Patients section of
Materials and methods). A generalized Equivalent Uniform
Dose (gEUD) constraint with emphasis on the high-dose
(k¼ 20) was used to control the hot spots in the target. The
requested PTV coverage was obtained using a Logarithmic
Tumor Control Probability (LTCP) function [22] as the highest
priority objective. Second priority was assigned to the mean
dose in the composite OAR, to be reduced to the full extent,
i.e., to the minimum possible value. The dose pushed away
from the OAR was further optimized with the PTV shell
objectives with priorities 3 and 4. The fifth priority objective
was added to deal with the clinical aim that the PTV mean
dose should approximate the prescribed dose. The aim of
the 6th priority objective was to further reduce dose in the
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OAR (see also priority 2) with an emphasis on high doses
(gEUD with k¼ 10). The same segmentation, MRL specific
settings and beam angles as in MANplanning were applied
in AUTOplanning.
Plan comparisons
For consistent dosimetric comparisons of AUTOplans with
MANplans based on equal PTV coverage, all plans were first
rescaled such that exactly 99% of the PTV received 95% of
the prescribed dose (as clinically requested), implying that in
all plans the near minimum dose, D99%, was equal to 95% of
the prescribed dose. In line with the clinical planning aims
(Manplanning section 2 of Materials and methods), we then
compared PTV V107%, PTV Dmean, OAR Dmean and
patient V40Gy.
The conformality index (CI, V95%/VPTV) and homogeneity
index (HI, 100(D1%,PTV - D99%,PTV)/D50%,PTV) were also eval-
uated, as well as planning times, numbers of MU, and treat-
ment delivery times. Two-sided paired Wilcoxon signed rank
tests were used for statistical analyses using a p< .05 as sig-
nificance level.
Dosimetric plan QA
For a subset of 5 arbitrarily selected patients, dosimetric QA
was performed at the MRL for the AUTOplan using the
Octavius 4D phantom and array (PTW, Freiburg, Germany).
Gamma evaluations were performed for the high dose region
(>50%) with 3% dose difference relative to the maximum
dose and 3mm distance to agreement [3%/3mm] criteria, as
applied in clinical practice at NKI.
Results
All generated MANplans and AUTOplans satisfied the require-
ments for clinical acceptability (Manplanning section 2 of
Materials and methods).
Table 2 shows population mean MANplan dosimetric
parameters and mean differences with AUTOplans. With
equal PTV coverage, AUTOplans had on average a small
advantage in PTV V107%, PTV Dmean, and homogeneity index
(HI). More important, the OAR Dmean was reduced by on
average 1.3 Gy (6.9%, p< .001)), with a maximum of 4.5 Gy
(23.8%). The AUTOplans had slightly increased patient V40Gy
(0.1%) and CI (0.1).
Figure 1 displays absolute dosimetric differences between
MANplans and AUTOplans for each patient. Positive differen-
ces (except for PTV Dmean) are in favor of the AUTOplans. For
20 of the 23 study patients (87%), the automated workflow
resulted in a lower mean dose in the OAR. PTV V107% and
PTV Dmean were improved for 18/23 (78%) and 17/23 (74%)
of the patients respectively. For 16/23 patients (70%) the
patient V40Gy was enhanced in the AUTOplans. Figure 2
shows the MANplan and the AUTOplan dose distribution for
an example patient.
Figure 3 shows for an example patient how the auto-
mated workflow defined by the wish-list (Table 1) could
avoid unacceptable high dose in the back of the patient
caused by the ERE and shifted build-up resulting from the
1.5 T magnetic field.
Table 1. Wish-list for automated rectal cancer treatment planning for an MRL.
Constraints
Structure Constraint function Limit
PTV gEUD(20) < 103% of PD
Back Maximum dose < 38 Gy
PTV shell at 5mm Maximum dose < 95% of PD
PTV shell at 1 cm Maximum dose < 90% of PD
PTV shell at 3 cm Maximum dose < 70% of PD
PTV shell at 5 cm Maximum dose < 65% of PD
PTV shell at 7 cm Maximum dose < 50% of PD
1 cm entrance dose shell Maximum dose < 50% of PD
Objectives
Priority Structure Aim & objective function Goal value (Sufficient)
1 PTV # LTCP(95% of PD,a¼0.8) 0.06 (0.06)
2 OAR # Mean dose 0
3 PTV shell at 7cm # Maximum dose 0
4 PTV shell at 2cm # Maximum dose 60% of PD
5 PTV " Mean dose PD (PD)
6 OAR # gEUD(10) 0
PD: Prescribed Dose (50 Gy); gEUD(k): generalized Equivalent Uniform Dose; k: volume parameter, LTCP(PD,a): Logarithmic
Tumor Control Probability [22], with a : cell sensitivity; OAR: composite organ at risk; #: minimization; ": maximization.Posterior to the PTV, the entrance dose shell was replaced by the back structure for separate steering on high dose in the back.
Table 2. Comparison of dosimetric plan parameters for MANplans
and AUTOplans.
MANplans MANplans – AUTOplans
Mean SE Mean Range p-Value
PTV
V95% [%] 99 – 0 – –
V107% [%] 0.4 0.1 0.2 [–0.7 – 1.4] <.01
Dmean [%] 50.2 0.3 –0.2 [–1.2 – 0.8] .04
CI [–] 1.1 0.0 –0.1 [–0.1 – 0.0] <.01
HI [%] 9.7 0.1 0.8 [–1.0 – 2.5] .02
OAR
Dmean [Gy] 18.9 0.5 1.3 [–1.0 – 4.5] <.01
Patient
V40Gy [%] 10.9 0.7 –0.1 [–0.7 – 0.6] .04
SE: standard error; PTV: planning target volume; OAR: organ at risk; CI: con-
formity index; HI: homogeneity index.All plans normalized to 99%.
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Planning times, Monitor Units and delivery times
Planning times reduced from 4–6h per patient for MANplans
(mainly hands-on time) to1h per patient for AUTOplans (mainly
computational time). The number of monitor units (MU) reduced
from 6776 214 for MANplans to 5896 90 for AUTOplans
(p< .01) MANplans had estimated delivery times of 3216 65 s
which reduced to 2746 47 s for the AUTOplans (p< .01).
Dosimetric plan QA
The QA measurements showed a 100% gamma passing rate
for all 5 patients. The median gamma ranged from 0.19 to
0.33, compared to 0.34 in the clinic.
Discussion
In this study we have developed the first system for fully
automated multi-criterial planning for a high magnetic field
MR-Linac (MRL). To this purpose, a Monte Carlo dose calcula-
tion engine, suited for high accuracy dose calculations in
a 1.5 T magnetic field, was coupled to our in-house Erasmus-
iCycle optimizer. An automated workflow including Erasmus-
iCycle and the clinical MRL TPS was configured for rectal
cancer treatment with an MRL at the NKI. AUTOplans were
superior to MANplans, especially regarding sparing of blad-
der and bowel bag, in line with the observed benefits of
automated planning for regular linacs [9,15,18,19,23].
Figure 1. Absolute differences in dosimetric plan parameters between the MANplans and AUTOplans for all 23 patients. Positive values indicate a better
AUTOplan. The first 5 patients were used to train the automated treatment planning workflow.
Figure 2. Dose distributions for the MANplan (left) and AUTOplan (right) for patient 14 (See Figure 1). The AUTOplan had clearly reduced dose in the OAR. Top:
axial view, bottom sagittal view. Magenta contour¼ PTV, Red contour¼OAR.
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Moreover, AUTOplanning allowed reductions of 13% in the
number of delivered MU and 15% in the treatment time. The
planning time reduced from 4–6 h per patient to around 1 h,
the latter mainly consisting of computer calculation time. It
was shown that automated treatment planning was feasible
for MRL rectum cancer treatment, despite the presence of a
1.5 T magnetic field that influences the dose deposition (i.e.,
electron return effect and shallower build-up dose). Also, the
limitations in the isocenter placement, collimator rotation
and beam angles, were no limiting factors in the automated
treatment planning workflow.
In this paper, the analyzed composite OAR consisted of
the bowel bag and the bladder, excluding the overlap with
the PTV. An additional analysis (not presented) for an OAR
that included the overlap region resulted in similar conclu-
sions regarding plan quality differences. This could be
expected as for all plans in this study (clinically and automat-
ically generated) the overlap region was treated as PTV, so a
homogenous coverage with high dose was always requested
with high priority.
In this study, all plans were generated with the same
beam configuration. Moreover, the applied number of beams
was relatively high [9]. Therefore, we believe that plan
robustness issues due to the presence of the high-magnetic
field and daily variations in anatomy may be small, and simi-
lar for clinically and automatically generated plans. Prior to
clinical application this can be verified for a group
of patients.
At the NKI, rectal cancer patients are currently treated
using a library-of-plans (LoP) strategy [15,24,25], requiring
patient-specific plan libraries with plans for various patient
anatomies. Automated plan generation can then greatly
reduce the planning workload, as was also observed for cer-
vical cancer treatment [26]. In addition, the use of the same
wish-list for all library plans could guarantee similar tradeoffs
between treatment goals along the entire treatment of the
patient, which is hard to achieve with manual treatment
planning. The superior image quality of in-room MR com-
pared to cone beam CT might render use of libraries with
enhanced numbers of plans possible. Creating these
extended libraries would practically only be feasible with
automatic plan generation.
Tools for on-line adaptive strategies are currently applic-
able in the clinical TPS, including the use of LoPs. Compared
to current clinical practice, the automated LoP-plan gener-
ation could increase plan quality of the adaptative LoP
workflow. However, full re-planning based on the anatomy
of the day can potentially further enhance plan quality. For
the longer future, multi-criterial optimizers are being devel-
oped that are fast enough for daily on-line re-planning based
on acquired MR images [27,28], which would require the use
of synthetic CT generation for online dose calculations. The
daily MR-based re-planning can then replace in principle the
plan library approach, ensuring maximum daily plan quality
while considering also the dose delivered in previous frac-
tions. Clinical application of daily MR-based re-planning
would require a sufficiently fast and safe procedure for the
daily contouring, preferentially not dependent on a clinician
that needs to stay at the treatment unit.
In this study, all AUTOplans were generated for a fixed
beam angle class solution, as used at the NKI. However,
Erasmus-iCycle also features individualized beam angle selec-
tion. In a future study we will use this option to investigate
potential advantages of optimized, patient-specific beam
arrangements. With the developed automated planning
workflow, many alternative plans with various beam arrange-
ments can be easily generated without user interaction.
Combined with the use of a single wish-list for all beam
angle configurations, a lot of intrinsic bias in conventional
trail-and-error treatment planning studies can be avoided
[29]. The investigated MRL system only allows coplanar treat-
ment. In previous studies using automated planning we
observed superiority of non-coplanar treatment compared to
coplanar [23]. However, in [23] equal PTV margins were used
for the coplanar and non-coplanar plans. Due to the
advanced imaging, it is to be expected that margins can be
largely reduced for the MRL. In future studies we will use
automated planning to compare MRL treatment with small
margins with non-coplanar treatment at a regular treatment
unit with larger margins.
In this paper we studied automated planning for the 1.5 T
Unity MR-linac. To the best of our knowledge fully auto-
mated planning has not yet been investigated for the
MRIdian treatment unit (Viewray Inc, Cleveland OH) with an
integrated 0.35 T MR scanner. Bohoudi et al. developed an
artificial neural network for knowledge-based prediction of
OAR constraints for pancreatic patients, which were used to
guide conventional, manual generation of final plans [30].
The Network was trained with plans that were manually gen-
erated with the clinical TPS. In a validation study for inde-
pendent cases (not used for network training), plans
Figure 3. Parts of axial dose distribution for patient 14 (in PTV and posterior to PTV) (a) clinically acceptable dose distribution without magnetic field (6MV con-
ventional linac plan). (b) clinically unacceptable dose distribution with magnetic field (MRL plan) but no dose control by back structure; too high dose in back struc-
ture (arrow) related to ERE and enhanced build-up due to the magnetic field. (c) clinically acceptable dose distribution with magnetic field (MRL plan) and dose
control using the back structure. Pink contour¼ PTV, dashed white contour¼ inactive back structure, solid white contour¼ active back structure. The treatment
couch matrass is located right below the back structure.
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generated with the help of the neural network and corre-
sponding clinical plans had similar quality.
Automated planning is currently not generally available
for the Unity MRL. However, the manufacturer is working on
a commercial implementation of the system presented here.
Conclusion
A system for fully automated multi-criterial planning for a
1.5 T MR-Linac has been developed and tested for rectal can-
cer patients. The impact of the high magnetic field on the
dose distribution could be controlled. The quality of the
automatically generated plans superseded that of plans gen-
erated with conventional trial-and-error planning. Moreover,
automated planning resulted in reduced MU and treatment
time and a major reduction in manual planning workload.
Automated planning has a high potential for further
improvement of advanced MRL treatment.
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